IGF-1 LR3: Community Protocols & Reports
Aggregated community experiences, protocols, and stacking patterns
Community-Sourced Information
The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.
For peer-reviewed dosing protocols, see the clinical dosing guide.
Browse community protocols for all 130 peptides โ
๐TL;DR
- โข4 community protocols documented
- โขEvidence level: Anecdotal Reports
- โขBased on 80 community reports
- โข3 stacking patterns reported
Clinical vs. Community Protocol Differences
How community-reported protocols differ from clinical research protocols.
| Aspect | Clinical Approach | Community Approach | Significance |
|---|---|---|---|
| Route of Administration | IGF-1 LR3 is primarily used as a cell culture supplement in research settings. Limited in vivo studies use IV or SubQ administration in animal models. | Community uses both subcutaneous (systemic) and intramuscular (site-specific) injection. IM injection into trained muscles is popular based on the belief that localized IGF-1 promotes site-specific growth. | high Site-specific IM injection for localized hypertrophy is a community concept with limited scientific support. IGF-1 LR3 has a long half-life and distributes systemically regardless of injection site. |
| Dose Range | Cell culture applications use nanogram concentrations. In vivo animal studies use weight-based dosing in the mcg/kg range. No human clinical studies have established therapeutic doses. | Community uses fixed doses of 20-100 mcg daily. The dose range has been established entirely through community self-experimentation. | high All community dosing is derived from anecdotal experience rather than clinical dose-finding studies. There is no validated human dosing data for IGF-1 LR3. |
| Hypoglycemia Risk | IGF-1 analogs are known to lower blood glucose through insulin-like activity. Native IGF-1 (mecasermin) carries FDA-labeled hypoglycemia warnings. | Community is aware of hypoglycemia risk and recommends having fast-acting carbohydrates available during use. Some users time injections with post-workout meals to mitigate blood sugar drops. | high Hypoglycemia is a serious risk with IGF-1 analogs. Community awareness is generally good but the lack of medical supervision increases risk. |
Compare these community approaches with published research findings.
Community Protocols
Standard Muscle Growth Protocol
Popular- Route
- Subcutaneous or Intramuscular
- Dose
- 20-50 mcg
- Frequency
- Once daily on training days
- Duration
- 4-6 weeks
Injected post-workout bilaterally into trained muscle groups or subcutaneously. Strict 4-6 week cycles to prevent desensitization.
Conservative/Beginner Protocol
Common- Route
- Subcutaneous
- Dose
- 20-40 mcg
- Frequency
- Once daily
- Duration
- 4 weeks
Lower-dose SubQ protocol for first-time users; start at 20 mcg and titrate up based on tolerance
Advanced Bodybuilding Protocol
Niche- Route
- Intramuscular (site-specific)
- Dose
- 50-100 mcg
- Frequency
- Once daily post-workout
- Duration
- 4-6 weeks
Higher-dose protocol split across 2-4 muscle groups post-workout. Carries higher hypoglycemia risk.
10-Day Alternating MGF/IGF-1 LR3 Protocol
Niche- Route
- Intramuscular
- Dose
- 40-50 mcg IGF-1 LR3 on alternating days
- Frequency
- Every other day (alternating with MGF)
- Duration
- 10-20 days per cycle
Alternates IGF-1 LR3 and MGF to target different phases of muscle repair and satellite cell activation
Stacking Patterns
IGF-1 LR3 + HGH
CommonCombines exogenous GH with direct IGF-1 receptor activation for enhanced anabolic effects; considered advanced due to complexity
IGF-1 LR3 + MGF Alternating Protocol
NicheAlternates between IGF-1 LR3 (growth and differentiation) and MGF (satellite cell activation) to target different phases of muscle repair
IGF-1 LR3 + PEG-MGF
NicheCombined growth factor approach; PEG-MGF for sustained satellite cell activation and IGF-1 LR3 for potent IGF-1R signaling
Check stack compatibility and review potential side effects before combining peptides.
Unlock community dosing protocols and stacking combos
See the exact doses, routes, and schedules 80+ self-experimenters report. Free with email.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Sources
- Reddit r/Peptides|IGF-1 LR3 experience reports and dosing discussions(accessed 2026-02-16)
- Reddit r/PeptideResearch|IGF-1 LR3 protocol and cycle length threads(accessed 2026-02-16)
- Swolverine|IGF-1 LR3 Cycle Protocols for Men and Women(accessed 2026-02-16)
- Peptides.org|IGF-1 LR3 Dosage Calculator and Chart(accessed 2026-02-16)
- Muscle and Brawn|IGF-1 LR3 Review for Bodybuilding (dosage, side effects)(accessed 2026-02-16)
- Revolution Health|The 10-Day Alternating MGF and IGF-1 LR3 Protocol(accessed 2026-02-16)
- PeptideDosages.com|IGF-1 LR3 1mg Vial Dosage Protocol(accessed 2026-02-16)
Community Evidence Overview#
This page presents aggregated community protocols and anecdotal reports for IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1). The information below is gathered from peptide research forums, Reddit communities, and self-experimenter reports. This is not clinical evidence and should not be used as medical guidance.
IGF-1 LR3 is a potent growth factor used in the bodybuilding and performance community for its anabolic effects. Unlike GH secretagogues which stimulate endogenous GH production, IGF-1 LR3 directly activates IGF-1 receptors with enhanced potency due to its reduced IGFBP binding.
Understanding Protocol Divergence#
No Human Clinical Data#
A critical distinction for IGF-1 LR3 is that it has no human clinical trial data. All community dosing, cycling, and administration practices are derived from self-experimentation. The compound is primarily manufactured as a cell culture supplement, and community use represents a significant departure from its intended application.
Site-Specific Injection#
The community practice of injecting IGF-1 LR3 intramuscularly into recently trained muscles is based on the belief that localized delivery enhances site-specific hypertrophy. However, given IGF-1 LR3's extended half-life (~20 hours), the peptide distributes systemically regardless of injection site, making the site-specific growth concept questionable.
Commonly Reported Outcomes#
Community members frequently report the following when using IGF-1 LR3:
- Muscle fullness: Increased muscle pumps and fullness during training
- Recovery: Enhanced recovery between training sessions
- Strength gains: Modest strength improvements during cycles
- Hypoglycemia: Some users report blood sugar drops, especially at higher doses
- Gut distention: A concern at higher doses or prolonged use, related to smooth muscle growth
Important Caveats#
- No human clinical data exists for IGF-1 LR3
- Hypoglycemia is a serious potential side effect requiring monitoring
- Long-term effects of exogenous IGF-1 receptor activation are unknown
- Product quality varies significantly between suppliers
- High-dose or prolonged use carries theoretical organ growth risks
Reconstitution and Storage Practices#
- Reconstitution: 0.6% acetic acid or bacteriostatic water per 1 mg vial
- Storage: Refrigerated at 2-8 degrees C; very sensitive to temperature
- Shelf life: Use within 2-3 weeks of reconstitution
- Note: IGF-1 LR3 is more fragile than many peptides; avoid vigorous shaking during reconstitution
Related Reading#
Subscribe to see vendor options
Free access to verified vendor scores, pricing, and suppliers.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Frequently Asked Questions About IGF-1 LR3
Explore Further
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.